MORVUS TECHNOLOGY LIMITED

Active Brecon

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MORVUS TECHNOLOGY LIMITED

Research and experimental development on biotechnology

Founded 28 Apr 2004 Active Brecon, Wales 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 25 Sept 2025 Next due 31 Jul 2026 3 months remaining
Confirmation Submitted 16 Dec 2025 Next due 14 Nov 2026 6 months remaining
Net assets £-2M £5M 2024 year on year
Total assets £83K £5M 2024 year on year
Total Liabilities £2M £136K 2024 year on year
Charges 5
5 satisfied

Contact & Details

Contact

Registered Address

Aberllech Pentre Bach Brecon LD3 8UB Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MORVUS TECHNOLOGY LIMITED (05115093), an active life sciences and medical technology company based in Brecon, Wales. Incorporated 28 Apr 2004. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£74.09k

Increased by £18.56k (+33%)

Net Assets

-£2.33M

Decreased by £5.12M (-184%)

Total Liabilities

£2.41M

Increased by £135.71k (+6%)

Turnover

N/A

Employees

2

Debt Ratio

2914%

Increased by 2869 (+6376%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2010Series A
Investor 2Feb 2010Series A

Share Capital

Share Capital

Share allotments and capital structure

40 Allotments 152,237,138 Shares £3399.45m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Jul 2023714,286£0£0
6 Feb 2023134,078£0£0
19 Dec 20223,529,412£4k£0.001
19 Dec 2022470,588£470.588£0.001
19 Dec 2022588,236£588.236£0.001

Officers

Officers

1 active 2 resigned
Status
David Graham BaynesDirectorBritishUnited Kingdom6217 Sept 2010Active

Shareholders

Shareholders (256)

Nathan International Holdings Ltd
15.3%
43,284,219
Michael Peter Mcbraida
14.3%
40,581,188

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

MORVUS TECHNOLOGY LIMITED Current Company
GORDIAN PHARMA LIMITED united kingdom

Charges

Charges

5 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Dec 2025Confirmation StatementConfirmation statement made on 2025-10-31 with no updates
25 Sept 2025AccountsAnnual accounts made up to 2024-10-31
6 Feb 2025OfficersTermination of Roger Spencer Jones as director on 2025-01-16
15 Nov 2024Confirmation StatementConfirmation statement made on 2024-10-31 with updates
29 Jul 2024AccountsAnnual accounts made up to 2023-10-31
16 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-10-31 with no updates

25 Sept 2025 Accounts

Annual accounts made up to 2024-10-31

6 Feb 2025 Officers

Termination of Roger Spencer Jones as director on 2025-01-16

15 Nov 2024 Confirmation Statement

Confirmation statement made on 2024-10-31 with updates

29 Jul 2024 Accounts

Annual accounts made up to 2023-10-31

Recent Activity

Latest Activity

Confirmation statement made on 2025-10-31 with no updates

4 months ago on 16 Dec 2025

Annual accounts made up to 2024-10-31

6 months ago on 25 Sept 2025

Termination of Roger Spencer Jones as director on 2025-01-16

1 years ago on 6 Feb 2025

Confirmation statement made on 2024-10-31 with updates

1 years ago on 15 Nov 2024

Annual accounts made up to 2023-10-31

1 years ago on 29 Jul 2024